Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy, Active”

222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 222 results

Early research (Phase 1)Not Yet RecruitingNCT06666153
What this trial is testing

Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromePTLDs
West China Hospital 27
Early research (Phase 1)Ended earlyNCT05233436
What this trial is testing

PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsGastric CancerGastroesophageal Junction Cancer+3 more
Pfizer 21
Testing effectiveness (Phase 2)Study completedNCT00510133
What this trial is testing

Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
Asterias Biotherapeutics, Inc. 21
Not applicableStudy completedNCT01085526
What this trial is testing

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Who this might be right for
Allergic Rhinoconjunctivitis
Aarhus University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03834948
What this trial is testing

AO-176 in Multiple Solid Tumor Malignancies

Who this might be right for
Solid Tumor
Arch Oncology 57
Early research (Phase 1)Study completedNCT00057915
What this trial is testing

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Duke University 4
Testing effectiveness (Phase 2)Study completedNCT03008304
What this trial is testing

High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02519348
What this trial is testing

Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
MedImmune LLC 433
Testing effectiveness (Phase 2)Study completedNCT00003433
What this trial is testing

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Duke Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT02763254
What this trial is testing

Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

Who this might be right for
Hodgkin LymphomaLymphoma, Large B-Cell, DiffusePost-transplant Lymphoproliferative Disorder
Cell Medica Ltd 1
Testing effectiveness (Phase 2)Study completedNCT00106613
What this trial is testing

A Research Study for Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellNeoplasm Metastasis
Celgene 30
Testing effectiveness (Phase 2)Study completedNCT02107404
What this trial is testing

Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 150
Testing effectiveness (Phase 2)Looking for participantsNCT05462106
What this trial is testing

Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Who this might be right for
Amyloid PlaqueBeta-AmyloidDSAD+2 more
AC Immune SA 176
Early research (Phase 1)UnknownNCT03599375
What this trial is testing

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, B-Cell
jiuwei cui 20
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Early research (Phase 1)Study completedNCT04306900
What this trial is testing

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Who this might be right for
Solid Tumor, Adult
Trishula Therapeutics, Inc. 185
Testing effectiveness (Phase 2)Study completedNCT00116597
What this trial is testing

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

Who this might be right for
Melanoma
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Ended earlyNCT00510471
What this trial is testing

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Genitope Corporation
Very early researchActive Not RecruitingNCT05358938
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 22
Load More Results